VERADERMICS Stock Price, News & Analysis
Company Description
VERADERMICS (NYSE: MANE) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $4.4B, ranking #1,559 among all listed U.S. companies by market cap.
MANE stock has gained 164.2% over the past year. Shares last traded at $99.72.
On a trailing twelve-month basis, VERADERMICS reported net income of -$70.0M and diluted earnings per share of $-111.91.
This page provides a comprehensive overview of MANE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VERADERMICS (MANE) stock last traded at $99.72, down 5.99% from the previous close. Over the past 12 months, the stock has gained 164.2%. At a market capitalization of $4.4B, MANE is classified as a mid-cap stock with approximately 41.2M shares outstanding.
MANE Rankings
Latest News
VERADERMICS has 10 recent news articles, with the latest published 2 days ago. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, private placement, offering, clinical trial, conferences. View all MANE news →
SEC Filings
VERADERMICS has filed 5 recent SEC filings, including 1 Form SCHEDULE 13G/A, 1 Form 10-Q, 1 Form 8-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MANE SEC filings →
Financial Highlights
operating income reached -$72.3M, and net income was -$70.0M. Diluted earnings per share stood at $-111.91. The company generated -$71.6M in operating cash flow. With a current ratio of 16.66, the balance sheet reflects a strong liquidity position.
Upcoming Events
Phase 3 '304' topline data
Study 304 topline readout
VERADERMICS has 2 upcoming scheduled events. The next event, "Phase 3 '304' topline data", is scheduled for July 1, 2026 (in 46 days). Investors can track these dates to stay informed about potential catalysts that may affect the MANE stock price.
Short Interest History
Short interest in VERADERMICS (MANE) currently stands at 1.8 million shares, down 22.8% from the previous reporting period, representing 4.7% of the float. Over the past 12 months, short interest has increased by 73.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for VERADERMICS (MANE) currently stands at 3.6 days, down 12% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 111.1% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.7 to 5.4 days.
MANE Company Profile & Sector Positioning
VERADERMICS (MANE) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NYSE.